Process for the production of a liquid mercapto-terminated polythioethersulfide comprising the step of reacting, at a temperature in the range 0-100° C. and in the presence of a catalyst: at least one compound selected from the group consisting of (i) dimercapto-dioxa-alkanes (DMDAs) and (ii) glycol di(mercapto carboxylic acid ester)s (GDMEs), at least one dimercapto-dialkyl sulfide (DMDS) at least one di-epoxide, and optionally at least one branching agent selected from compounds having at least three terminal groups selected from epoxy and mercapto groups,
wherein the molar ratio (DMDA+GDME)/DMDS is in the range 1.1-4.0.

Curable sealant compositions comprise the components: a) x weight percent of at least one polythiol; b) y weight percent of at least one unsaturated compound having at least two non-aromatic carbon-carbon double bonds, at least one carbon-carbon triple bond, or a combination thereof; c) from 0.01 to 8 weight percent of at least one quaternary ammonium or phosphonium salt; d) from 0.05 to 10 weight percent of at least one organic peroxide; and e) optionally from 0.01 to 10 weight percent of a photoinitiator system capable of generating free radicals upon exposure to actinic radiation. Each of x and y represents a positive real number. The sum x+y is in the range of 72 to 99. The weight percent ranges of the components a)-e) are based on the total weight of the components a)-e). A seal cap including the curable sealant composition and methods of making and using the curable sealant compositions are also disclosed.

Process for the production of a liquid mercapto-terminated polythioethersulfide comprising the step of reacting, at a temperature in the range 0-100° C. and in the presence of a catalyst: at least one compound selected from the group consisting of (i) dimercapto-dioxa-alkanes (DMDAs) and (ii) glycol di(mercapto carboxylic acid ester)s (GDMEs), at least one dimercapto-dialkyl sulfide (DMDS) at least one di-epoxide, and optionally at least one branching agent selected from compounds having at least three terminal groups selected from epoxy and mercapto groups,
wherein the molar ratio (DMDA+GDME)/DMDS is in the range 1.1-4.0.

Provided are methods for linking polypeptides (including peptides and proteins) to other moieties using radical imitated thiol-ene chemistries, for example, modifying a polypeptide by introducing reactive thiol groups and reacting the thiol groups with olefin-containing reagents or alkyne-containing reagents under conditions that support radical thiol-ene or thiol-yne reactions. The reactive thiol groups have greater activity for radical thiol-ene reactions that a cysteine thiol group, including thiol groups that are separated from the peptide backbone by at least two carbon atoms, for example, the thiol group of a homocysteine residue. Also provided are compositions and biomaterials containing the linked polypeptides, for example, peptide and protein conjugates, and thiol-ene based biocompatible hydrogel polymers, and their uses in the medical field.

Provided are methods for linking polypeptides (including peptides and proteins) to other moieties using radical imitated thiol-ene chemistries, for example, modifying a polypeptide by introducing reactive thiol groups and reacting the thiol groups with olefin-containing reagents or alkyne-containing reagents under conditions that support radical thiol-ene or thiol-yne reactions. The reactive thiol groups have greater activity for radical thiol-ene reactions that a cysteine thiol group, including thiol groups that are separated from the peptide backbone by at least two carbon atoms, for example, the thiol group of a homocysteine residue. Also provided are compositions and biomaterials containing the linked polypeptides, for example, peptide and protein conjugates, and thiol-ene based biocompatible hydrogel polymers, and their uses in the medical field.

Polyethylene glycol (PEG)-b-poly(β-amino ester) (PBAE) co-polymers (PEG-PBAE) and blends of PEG-PBAEs and PBAEs and their use for delivering drugs, genes, and other pharmaceutical or therapeutic agents safely and effectively to different sites in the body and to different cells, such as cancer cells, are disclosed.

Polyethylene glycol (PEG)-b-poly(β-amino ester) (PBAE) co-polymers (PEG-PBAE) and blends of PEG-PBAEs and PBAEs and their use for delivering drugs, genes, and other pharmaceutical or therapeutic agents safely and effectively to different sites in the body and to different cells, such as cancer cells, are disclosed.

The polymerizable composition of the present application may exhibit a wide process window to have excellent workability, and may form a phthalonitrile resin having excellent heat resistance or a prepolymer thereof.

The polymerizable composition of the present application may exhibit a wide process window to have excellent workability, and may form a phthalonitrile resin having excellent heat resistance or a prepolymer thereof.

A dual curable thiol-ene composition comprising a polythiol, an unsaturated compound, a photoinitiator, an organic hydroperoxide (thermal initiator) and optionally a nitrogen-containing base, such as e.g. an N-heterocyclic compound (together with the organic hydroperoxide a redox initiator system). A cross-linked polymer prepared therefrom. A method of making such a polymer. A cured sealant comprising such a polymer. The sealant is preferably for use in aerospace.